OpenAlex
PricingAboutJobs
Log inGet started
Work

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

HTML

Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Molecular Psychiatry
DOI: 10.1038/sj.mp.4001805
Authors: N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst, H-J Möller, V Arolt, M Riedel
Institutions: Ludwig-Maximilians-Universität München, University of Münster
Language: English

Topic: Treatment of Major Depression
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: celecoxib, COX-2 inhibitors, major depressive disorder, reboxetine, anti-inflammatory therapy, inflammatory cytokines, prostaglandin E2, adjunctive therapy, acute depressive episode
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2049808835
FWCI: 19.05
Cites: 37
Cited by: 872
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security